David E. Williams is co-founder of the Health Business Group and MedPharma Partners, and author of the Health Business Blog.
Earlier he worked for ten years in the health care practice of the Boston Consulting Group and as an independent consultant. He began his career at the LEK Partnership, where he was a strategy consultant and mergers and acquisitions advisor in a variety of industries.
David holds a BA in Economics from Wesleyan University, where he was elected to Phi Beta Kappa, and an MBA from Harvard Business School, with First Year Honors. He has acted as an instructor in MIT’s graduate-level Dynamics of Biomedical Technologies course in the Biomedical Enterprise Program.
David is a board member of iCardiac Technologies, a Pfizer- funded company that is commercializing advanced safety biomarkers for pharmaceutical development and Candescent Healing, a private equity backed wound care services company. He serves on the advisory board of the Center for the Evaluation of Value and Risk in Health Care at Tufts University Medical Center (a comparative effectiveness research organization) and is chairman of the Hearts & Noses Hospital Clown Troupe, a provider of professionally trained volunteer clowns to hospitalized children. He is also on the advisory board of Boston Young Healthcare Professionals. From 2006 to 2011 he served as chairman of online medical risk management and continuing medical education provider Advanced Practice Strategies, leading the company through an 8x increase in revenue and 30x increase in valuation in two rounds of venture capital financing.
David chaired a review panel for the Department of Health and Human Services as part of the Office of the National Coordinator for Health Information Technology’s Regional Extension Center (REC) program, which reviewed applications under the ARRA/HITECH Act. He also served on ONC review panels for the Beacon Community Cooperative Agreement Program and State Health Information Exchange Challenge Program and later chaired a panel to conduct a biennial review of the RECs. Most recently he chaired a review panel for the Exchange Navigators under the Affordable Care Act.
He is frequently quoted in the media health care topics and is the author of the Health Business Blog, where he has shared his interpretation of health care business and policy issues in more than 3500 posts since 2005.
Patrick Kager is a co-founder of MedPharma Partners and the Health Business Group and has over 15 years of consulting experience working with pharmaceutical, biotechnology, medical device and health care organizations. Before his current role, he was a Partner in Deloitte Consulting’s Life Sciences practice. There he led creation of the firm’s pharmaceutical R&D and M&A market offerings while serving as lead client service partner for several top-10 pharmaceutical and biotech companies. Before Deloitte Consulting, Pat was a senior manager in the Boston Consulting Group’s health care practice.
Pat has successfully completed over 100 client engagements in the areas of corporate strategy, product development and commercialization strategy, R&D management, manufacturing and supply chain management, sales and marketing effectiveness, mergers and acquisitions, business process design and IT strategy. He has authored several articles for Harvard Business Review, Pharmaceutical Executive, and other journals examining topics of interest to the pharmaceutical and biotech industries and providing practical guidance to managers facing difficult business situations.
Pat holds a BS in electrical engineering and mathematics and an MS in computer engineering from Carnegie-Mellon University and earned an MBA with Distinction from Dartmouth’s Amos Tuck School of Business Administration. He also holds Series 7 and 63 licenses.
Karen Donovan has held several senior strategic and operating roles at health care services, health care software, and consulting firms. She began her career more than 20 years ago at The LEK Partnership, where she led strategic development projects, M&A screenings, and competitive benchmarking for managed care, health care services, medical technology, and diagnostics clients. As Director of Strategic Development at VITAS Healthcare, she helped develop clinical, financial, and operating software systems and best practices for operations in 31 cities, spanning home health, long-term care, and hospital care settings. In addition, she led the development of a contract services subsidiary to provide these systems and services to outside companies. As VP of Operations at CareTools, an enterprise-wide health care software company, Karen oversaw customer sales and systems implementations for customer segments that included disease management companies, physician practice management, and MSO companies.
As an independent consultant, she provided strategic expertise to investment, health care services, health care IT, and pharmaceutical clients. At Health Business Group she has performed numerous market assessments and M&A evaluations in health care technology, services, and payer markets. She has extensive experience in strategic planning and sustainability assignments with non-profit and multi-stakeholder organizations.
Karen has a BS in Economics from the Wharton School of Business at the University of Pennsylvania, where she was on the Dean’s List. She is an active angel investor in early-stage healthcare companies and a board member for Bliss Healthcare, an integrated software and services solutions company serving healthcare providers.
Amy M. Lischko, MSPH, D. Sc. has over twenty five years of health services research experience. She worked for the Commonwealth of Massachusetts in senior-level positions under the Weld, Swift and Romney administrations. Until 2007, Amy led a 100-person agency within the Office of Health and Human Services and was concurrently the health policy advisor to the secretary. She holds a doctorate degree in health services research from Boston University with a concentration in quality measurement. During her tenure with state government Amy oversaw various research and policy activities and she was one of the key authors of the administration’s health care reform legislation. She also led the state’s initial efforts in increasing the transparency of health care quality and cost information by establishing a consumer website.
Amy began a faculty position at Tufts University School of Medicine in July 2007 and is currently an Associate Professor of Public Health and Community Medicine. She has provided consulting services to numerous organizations and individual states around various aspects of health care reform and quality improvement. Amy’s research interests are focused on using data to develop strategies for constraining health care costs while improving quality. She is interested in bridging the gap between academic researchers and policymakers by making academic research more accessible to policymakers.
At Health Business Group, Amy focuses on economic analysis and growth strategies for health care providers and multi-stakeholder non-profit organizations.
Trevor McCaw is an experienced consultant, entrepreneur and Fortune 500 manager, with substantial expertise in health care services, information technology and medical devices. Before joining Health Business Group, Trevor worked in Minneapolis for Medtronic’s Patient Management Group where he focused on the planning and launch of CareLink, Medtronic’s industry-leading remote patient monitoring technology. He was responsible for adding a new class of devices to CareLink, which included establishing overall strategic/product planning objectives, working with the FDA on 510k approval, interfacing with CMS to establish reimbursement, training the salesforce, preparing market launch material and creating a customer support infrastructure. Trevor was named one of only 30 “Emerging Leaders” within the company by Medtronic’s executive management.
Prior to Medtronic Trevor worked as a consultant for the Boston Consulting Group and Innosight. As an entrepreneur, Trevor founded Sentinel Medical Technologies, a health care technology commercialization company, and co-founded an enterprise software company that went public in 2001 on the AIM stock exchange.
Trevor received a Bachelor of Electrical Engineering from Queen’s University in Canada and an MBA from Harvard Business School.
John Seus has 20 years of health care industry and consulting experience. He started his career in pharmaceutical R&D at Procter & Gamble. Later, John was a partner for eight years at A.T. Kearney and Deloitte Consulting.
John has led projects in strategy, operations and technology for clients in all sectors of the health care industry. He has extensive experience in assisting medical device companies with all aspects of strategy and commercial operations including market assessment, technology assessment, new product launch, pricing, marketing strategy, sales force structure and management and channel strategy. He has assisted clients in establishing value platforms for key products and technologies and bringing them to market including products in orthopedics, cardiology, minimally invasive surgery, transplantation and in-vitro diagnostics as well as computer operating systems and supply chain technologies.
He also has deep experience in operations improvement, benchmarking, cost reduction, outsourcing and functional strategy development in manufacturing and supply chain, R&D, finance and other back office functions for pharmaceutical, biopharmaceutical and medical device companies.
John holds a B.S. in chemical engineering from the University of Massachusetts at Amherst where he was ranked second in his class. He received his MBA from Harvard where he focused on finance and operations.
Mack Amaker has provided and directed business process and technical consulting services for more than 20 years. His primary areas of focus include health care services, pharmaceuticals, medical devices, logistics, and consumer goods. His expertise spans process and technical innovation, solution design and implementation.
Selected accomplishments include:
- Built and managed a 25-person information technology organization to support business operations for an international medical equipment company
- Directed a 60-person project to implement shared architecture, customer relationship and financial services to reduce operating costs by 15 to 20 percent for a major equipment manufacturer
- Integrated a new contract management system to provide more accurate and timely financial data and reduce capital costs for a major health insurer
- Developed the financial procurement and payment strategy and identified related web technologies to substantially reduce supplies, materials and internal operating costs for a major pharmaceutical company
- Designed the processes and web-based technologies for tracking capital projects globally to reduce total capital spend for a major pharmaceutical company
Mack is a Certified Public Accountant in New Jersey and Georgia. He has worked for major accounting and software firms.